Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Naoki Ishizuka"'
Autor:
Shigeo Nakamura, Masahiko Oguchi, Tomohiro Kinoshita, Nobuko Kubota, Noriko Usui, Naoki Ishizuka, Tadashi Yoshino, Kunihiro Tsukasaki, Kuniaki Itoh, Yukio Kobayashi, Kana Miyazaki, Kenichi Ishizawa, Yasushi Isobe, Yoshihiro Matsuno, Kazuo Oshimi, Kensei Tobinai, Katsuyoshi Takata, Motoko Yamaguchi, Izumi Wasada
Publikováno v:
Cancer Science
Concurrent chemoradiotherapy has become one of the standard management approaches for newly diagnosed localized nasal natural killer (NK)/T-cell lymphoma (NKTCL). Few data are available on the prognostic biomarkers of NKTCL among patients treated wit
Autor:
Naoki Ishizuka, Taito Esaki, Yuh Sakata, Yasutsuna Sasaki, Shu Okamura, Yoshihiro Kakeji, Tomohiro Nishina, Yasuhide Yamada, Toshimasa Tsujinaka, Wasaburo Koizumi, Takashi Ura, Masaki Munakata, Taroh Satoh, Ichinosuke Hyodo, Kentaro Yamazaki
Publikováno v:
Cancer Science. 102:1868-1873
Irinotecan-induced severe neutropenia is associated with homozygosity for the UGT1A1*28 or UGT1A1*6 alleles. In this study, we determined the maximum-tolerated dose (MTD) of irinotecan in patients with UGT1A1 polymorphisms. Patients who had received
Publikováno v:
Cancer science. 94(8)
To clarify the long-term survival data and factors that are correlated with survival outcome of unresectable locally advanced non-small cell lung cancer (NSCLC) following chemoradiotherapy, we analyzed patients who entered the Japan Clinical Oncology